ASCIA News
-
New PBS Listed Treatment for ANCA Associated Vasculitis - October 2024
In response to an application by CSL Seqirus to the Pharmaceutical Benefits Advisory Committee (PBAC), the Pharmaceutical Benefits Scheme (PBS) listing of Tavneos® (avacopan) that was recommended by the PBAC in March 2024 has come into effect on 1 October 2024. This... -
Biologics in Severe Asthma - Change in PBS Criteria - October 2024
In response to an application by GSK to the Pharmaceutical Benefits Advisory Committee (PBAC) to remove the oral corticosteroid (OCS) requirement to qualify for biologics in uncontrolled severe asthma, the Pharmaceutical Benefits Scheme (PBS) OCS criteria change that was... -
ASCIA 2024 Conference Report
The ASCIA 2024 Conference was held from Tuesday 3rd to Friday 6th September 2024 at the Adelaide Convention Centre. This was a hybrid conference, which enabled virtual or in-person attendance, and on-demand viewing of sessions for all registered delegates for up to six... -
ASCIA Annual General Meeting 2024
A total of 117 ASCIA members (81 in-person and 36 online) attended the ASCIA Annual General Meeting (AGM) which was held during the ASCIA 2024 Conference week, on Thursday 5 September 2024, at the Adelaide Convention Centre, The ASCIA AGM 2024 Minutes are available on the... -
Shingrix Vaccine to Prevent Shingles - September 2024 Update
Shingrix® is a varicella zoster virus recombinant vaccine that can provide protection from herpes zoster (shingles) and post-herpetic neuralgia (long-term nerve pain). Further to ASCIA advocating for funded access to Shingrix® for people with immune deficiencies on the... -
Updated ASCIA OIT for Food Allergy FAQ
ASCIA Oral Immunotherapy (OIT) for Food Allergy Frequently Asked Questions (FAQ) for patients and carers has been updated to include more information about safety concerns. The updated FAQ is available on the ASCIA website... -
Recent ASCIA Website Updates - Immunodeficiency and Autoimmunity
Recent ASCIA website updates that are relevant to immunodeficiency and autoimmunity include: Shingrix Vaccine to Prevent Shingles - September 2024 Update New ASCIA Clinical Care Standard for Inborn Errors of Immunity (IEI)/ Primary Immunodeficiencies (PID) New ASCIA... -
Recent ASCIA Website Updates - Anaphylaxis and Allergy
Recent ASCIA website updates that are relevant to anaphylaxis and allergy include: ASCIA Oral Immunotherapy (OIT) for Food Allergy Frequently Asked Questions (FAQ) for patients and carers - updated to add statements about impact on daily life and factors that can increase the...
ASCIA Member Login
Site last updated: 3 Oct 2024
ASCIA Update
Information for the community about allergic diseases, immunodeficiencies and other immune diseases.